SOPHiA GENETICS SA (NASDAQ: SOPH) reported Q2 EPS of ($0.33), $0.04 worse than the analyst estimate of ($0.29). Revenue for the quarter came in at $15.1 million versus the consensus estimate of $15.24 million.

For earnings history and earnings-related data on SOPHiA GENETICS SA (SOPH) click here.